Retrovirology

official impact factor 5.24

Open Access Highly Access

The aftermath of the Merck's HIV vaccine trial

Enrico Iaccino, Marco Schiavone, Giuseppe Fiume, Ileana Quinto and Giuseppe Scala*

Retrovirology 2008, 5:56 doi:10.1186/1742-4690-5-56

Accesses  

  • Last 30 days: 98 accesses
  • Last 365 days: 975 accesses
  • All time: 5006 accesses